Published in J Virol on June 01, 2000
Antiviral actions of interferons. Clin Microbiol Rev (2001) 13.06
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med (2005) 5.09
Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A (2003) 5.05
B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol (2003) 4.87
Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol (2005) 4.31
Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol (2005) 3.59
Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol (2006) 3.23
Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol (2005) 3.08
A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med (2003) 2.89
Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol (2004) 2.83
Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol (2006) 2.76
West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol (2005) 2.72
Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol (2000) 2.49
Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol (2005) 2.44
NS5 of dengue virus mediates STAT2 binding and degradation. J Virol (2009) 2.42
The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway. J Virol (2004) 2.37
Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol (2005) 2.37
Infection and injury of neurons by West Nile encephalitis virus. J Virol (2003) 2.25
Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J Clin Microbiol (2007) 2.15
Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice. J Virol (2003) 2.13
Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol (2004) 2.01
A protective role for dengue virus-specific CD8+ T cells. J Immunol (2009) 1.98
Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J Virol (2005) 1.97
Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J Virol (2006) 1.91
Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis (2007) 1.86
Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol (2006) 1.84
Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS One (2009) 1.82
DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog (2012) 1.80
Flow cytometry-based assay for titrating dengue virus. J Clin Microbiol (2005) 1.78
Complement activation is required for induction of a protective antibody response against West Nile virus infection. J Virol (2005) 1.75
Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol (2003) 1.65
The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. Cell Host Microbe (2014) 1.61
Effects of length and location on the cellular response to double-stranded RNA. Microbiol Mol Biol Rev (2004) 1.57
Mouse models of dengue virus infection and disease. Antiviral Res (2008) 1.56
STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog (2011) 1.54
RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis (2011) 1.50
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A (2012) 1.48
Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. J Virol (2008) 1.48
Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol (2010) 1.45
Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog (2012) 1.44
Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol (2010) 1.42
RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J Virol (2006) 1.38
Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro. J Virol (2002) 1.35
The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis. Virology (2008) 1.31
Secreted Vago restricts West Nile virus infection in Culex mosquito cells by activating the Jak-STAT pathway. Proc Natl Acad Sci U S A (2012) 1.29
Innate immunity evasion by Dengue virus. Viruses (2012) 1.29
Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles. J Virol (2010) 1.27
Cardif-mediated signaling controls the initial innate response to dengue virus in vivo. J Virol (2009) 1.27
Progress on the development of therapeutics against West Nile virus. Antiviral Res (2009) 1.26
Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol (2002) 1.25
Patterns of gene transcript abundance in the blood of children with severe or uncomplicated dengue highlight differences in disease evolution and host response to dengue virus infection. J Infect Dis (2009) 1.24
Beta interferon controls West Nile virus infection and pathogenesis in mice. J Virol (2011) 1.23
Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system. J Virol (2007) 1.23
Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA. Virol J (2005) 1.21
Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS Pathog (2013) 1.20
Models of dengue virus infection. Drug Discov Today Dis Models (2006) 1.18
Innate immunity to dengue virus infection and subversion of antiviral responses. J Mol Biol (2013) 1.17
Dengue virus utilizes a novel strategy for translation initiation when cap-dependent translation is inhibited. J Virol (2006) 1.17
Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J Virol (2011) 1.15
Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int J Exp Pathol (2005) 1.15
Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF. PLoS Negl Trop Dis (2012) 1.14
Unusual dengue virus 3 epidemic in Nicaragua, 2009. PLoS Negl Trop Dis (2011) 1.10
Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus. J Leukoc Biol (2008) 1.09
Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production. BMC Infect Dis (2010) 1.04
Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity. Front Immunol (2014) 1.01
Identification of novel small-molecule inhibitors of West Nile virus infection. J Virol (2007) 1.00
Endothelial cells elicit immune-enhancing responses to dengue virus infection. J Virol (2012) 1.00
Randomized, placebo-controlled trial of nonpegylated and pegylated forms of recombinant human alpha interferon 2a for suppression of dengue virus viremia in rhesus monkeys. Antimicrob Agents Chemother (2005) 0.97
Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures. Immunol Res (2009) 0.97
Delayed cytosolic exposure of Japanese encephalitis virus double-stranded RNA impedes interferon activation and enhances viral dissemination in porcine cells. J Virol (2011) 0.95
Early dengue virus protein synthesis induces extensive rearrangement of the endoplasmic reticulum independent of the UPR and SREBP-2 pathway. PLoS One (2012) 0.95
Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-β in cultured hepatoma cells. PLoS One (2011) 0.95
Roles for endothelial cells in dengue virus infection. Adv Virol (2012) 0.95
Inhibition of dengue virus entry and multiplication into monocytes using RNA interference. PLoS Negl Trop Dis (2011) 0.94
Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS One (2010) 0.92
Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines. J Virol (2014) 0.91
Susceptibility and response of human blood monocyte subsets to primary dengue virus infection. PLoS One (2012) 0.91
Cells in dengue virus infection in vivo. Adv Virol (2010) 0.90
Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone. J Virol (2001) 0.88
Evasion of the human innate immune system by dengue virus. Immunol Res (2012) 0.87
Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and mice. J Med Virol (2008) 0.87
Dengue and soluble mediators of the innate immune system. Trop Med Health (2011) 0.87
Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery. J Interferon Cytokine Res (2014) 0.84
Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS. J Virol (2016) 0.83
Dengue virus activates membrane TRAIL relocalization and IFN-α production by human plasmacytoid dendritic cells in vitro and in vivo. PLoS Negl Trop Dis (2013) 0.83
Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases-Not Glycolipid Processing Enzymes. PLoS Negl Trop Dis (2016) 0.83
Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control. J Interferon Cytokine Res (2015) 0.83
Mechanisms controlling virulence thresholds of mixed viral populations. J Virol (2011) 0.81
Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection. Antiviral Res (2006) 0.80
STAT2 signaling and dengue virus infection. JAKSTAT (2014) 0.80
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections. Biomed Res Int (2013) 0.80
Mosquito Saliva Increases Endothelial Permeability in the Skin, Immune Cell Migration, and Dengue Pathogenesis during Antibody-Dependent Enhancement. PLoS Pathog (2016) 0.80
Protein kinase regulated by dsRNA downregulates the interferon production in dengue virus- and dsRNA-stimulated human lung epithelial cells. PLoS One (2013) 0.79
Imunocompetent mice model for dengue virus infection. ScientificWorldJournal (2012) 0.78
Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques. Immunogenetics (2011) 0.78
Time since onset of disease and individual clinical markers associate with transcriptional changes in uncomplicated dengue. PLoS Negl Trop Dis (2015) 0.78
How cells respond to interferons. Annu Rev Biochem (1998) 24.27
Pathogenesis of dengue: challenges to molecular biology. Science (1988) 14.73
Cellular responses to interferon-gamma. Annu Rev Immunol (1997) 13.23
Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods (1974) 8.28
Dengue: the risk to developed and developing countries. Proc Natl Acad Sci U S A (1994) 7.76
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med (1997) 6.57
Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology (1997) 4.88
Dengue virus structural differences that correlate with pathogenesis. J Virol (1999) 4.26
Antibody-enhanced dengue virus infection in primate leukocytes. Nature (1977) 4.18
Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet (1999) 3.97
Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR. J Clin Microbiol (1998) 3.65
Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther (1998) 3.64
Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis (1989) 3.53
Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol (1998) 3.51
New mouse model for dengue virus vaccine testing. J Virol (1999) 3.18
Immunopathogenesis of Dengue hemorrhagic fever. Virology (1999) 3.16
Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis (1999) 2.96
Comparative study of different standardization concepts in quantitative competitive reverse transcription-PCR assays. J Clin Microbiol (1998) 2.68
Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol (1990) 2.47
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest (1991) 2.37
Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am J Trop Med Hyg (1999) 2.20
Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J Virol (1998) 2.03
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest (1989) 2.01
Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol (1988) 1.71
Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun (1982) 1.69
Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Trop Med Hyg (1980) 1.65
Molecular evolution of dengue type 2 virus in Thailand. Am J Trop Med Hyg (1998) 1.63
Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl (1994) 1.61
High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg (1993) 1.56
Fatal dengue hemorrhagic fever in Cuba, 1997. Int J Infect Dis (1999) 1.55
Antibody response in dengue and dengue hemorrhagic fever. Jpn J Med Sci Biol (1967) 1.47
Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol (1997) 1.40
Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes. Arch Virol (1989) 1.29
Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor. J Biol Chem (1996) 1.27
Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infections. Arch Virol (1990) 1.27
Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. J Med Virol (1999) 1.16
Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF. Arch Virol (1992) 1.16
Human immune responses to dengue viruses. Southeast Asian J Trop Med Public Health (1990) 1.15
Production of interferon alpha by dengue virus-infected human monocytes. J Gen Virol (1988) 1.08
Induction of interferon alpha from human lymphocytes by autologous, dengue virus-infected monocytes. J Exp Med (1987) 1.03
Analysis of antibody-independent binding of dengue viruses and dengue virus envelope protein to human myelomonocytic cells and B lymphocytes. Virus Res (1998) 1.01
Lack of augmenting effect of interferon-gamma on dengue virus multiplication in human peripheral blood monocytes. J Med Virol (1995) 1.00
Therapy of acute and chronic viral hepatitis. Adv Intern Med (1994) 0.99
Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. J Interferon Res (1990) 0.98
The effect of interferon on Japanese encephalitis virus in vitro. Southeast Asian J Trop Med Public Health (1984) 0.97
T cell activation in vivo by dengue virus infection. J Clin Lab Immunol (1995) 0.95
Effect of cytokines on Japanese encephalitis virus production by human monocytes. Microbiol Immunol (1990) 0.94
The effect of interferon on flaviviruses in vitro: a preliminary study. Southeast Asian J Trop Med Public Health (1984) 0.89
Rapid competitive PCR determination of relative gene expression in limiting tissue samples. Clin Chem (1996) 0.80
Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet (1990) 7.04
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A (1980) 6.31
Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell (1994) 4.53
Mutations in RPE65 cause Leber's congenital amaurosis. Nat Genet (1997) 4.48
Metabolic regulation of brain Abeta by neprilysin. Science (2001) 4.47
Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature (1996) 4.41
A single amino acid can determine the DNA binding specificity of homeodomain proteins. Cell (1989) 4.05
Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell (1996) 3.91
Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med (2000) 3.84
The C5a chemoattractant receptor mediates mucosal defence to infection. Nature (1996) 3.73
Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR. J Clin Microbiol (1998) 3.65
Obesity and inequities in health in the developing world. Int J Obes Relat Metab Disord (2004) 3.49
Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med (1999) 3.23
A new class of angiotensin-converting enzyme inhibitors. Nature (1980) 3.03
Development of an extremely wear-resistant ultra high molecular weight polyethylene for total hip replacements. J Orthop Res (1999) 2.81
Refined solution structure of the oligomerization domain of the tumour suppressor p53. Nat Struct Biol (1995) 2.75
Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning signals in Xenopus. Nature (1995) 2.75
PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol (2001) 2.69
A conserved system for dorsal-ventral patterning in insects and vertebrates involving sog and chordin. Nature (1995) 2.58
Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer. Nature (1996) 2.54
Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol (2000) 2.49
Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell (1997) 2.44
Intracellular crowding defines the mode and sequence of substrate uptake by Escherichia coli and constrains its metabolic activity. Proc Natl Acad Sci U S A (2007) 2.42
The paired box encodes a second DNA-binding domain in the paired homeo domain protein. Genes Dev (1991) 2.35
The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J Neurosci (2000) 2.28
Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci (1999) 2.26
A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature (2000) 2.24
Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am J Trop Med Hyg (1999) 2.20
Neurogenic amplification of immune complex inflammation. Science (1996) 2.05
Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus. Nat Genet (1999) 2.04
BMP-binding modules in chordin: a model for signalling regulation in the extracellular space. Development (2000) 2.02
The mouse Engrailed-1 gene and ventral limb patterning. Nature (1996) 1.98
Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903. HIV Med (2006) 1.97
Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Study of Osteoporotic Fractures Research Group. Ann Intern Med (2000) 1.94
Performance characteristics of a rapid HIV antibody assay in a hospital with a high prevalence of HIV infection. CDC-Bronx-Lebanon HIV Serosurvey Team. Ann Intern Med (1996) 1.90
The ultimate speed of magnetic switching in granular recording media. Nature (2004) 1.89
Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology (2001) 1.87
Fate mapping of the mouse midbrain-hindbrain constriction using a site-specific recombination system. Curr Biol (1998) 1.83
Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J Exp Med (1997) 1.83
PCR detection and identification of Leishmania parasites in clinical specimens in Ecuador: a comparison with classical diagnostic methods. J Parasitol (1999) 1.80
Simplified polymerase chain reaction detection of new world Leishmania in clinical specimens of cutaneous leishmaniasis. Am J Trop Med Hyg (1998) 1.76
Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am J Transplant (2010) 1.74
The transmission of refractive errors within eskimo families. Am J Optom Arch Am Acad Optom (1969) 1.66
Presynaptic modulation of synaptic transmission and plasticity by brain-derived neurotrophic factor in the developing hippocampus. J Neurosci (1998) 1.63
PI-3 kinase and IP3 are both necessary and sufficient to mediate NT3-induced synaptic potentiation. Nat Neurosci (2001) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Effect of sterilization method and other modifications on the wear resistance of acetabular cups made of ultra-high molecular weight polyethylene. A hip-simulator study. J Bone Joint Surg Am (2000) 1.58
Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis. J Clin Invest (1998) 1.57
Risk factors associated with recent transmission of tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis (2009) 1.54
Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene (2009) 1.54
Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat Immunol (2001) 1.51
Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest (1997) 1.51
Regressive and reactive changes in the connectivity patterns of rod and cone pathways of P23H transgenic rat retina. Neuroscience (2004) 1.46
A call for health policy education in the medical school curriculum. JAMA (1995) 1.46
A developmentally regulated microsomal protein specific for the pigment epithelium of the vertebrate retina. J Neurosci Res (1993) 1.45
Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest (2000) 1.44
The homeodomain: a new face for the helix-turn-helix? Bioessays (1992) 1.42
Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery. Cell Death Differ (2011) 1.42
Maternal and Infant Services: examination of access in a culturally diverse community. J Paediatr Child Health (2003) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Neurotrophins promote maturation of developing neuromuscular synapses. J Neurosci (1995) 1.41
Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation (2005) 1.40
Endoderm induction by the organizer-secreted factors chordin and noggin in Xenopus animal caps. EMBO J (1996) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Gamma irradiation: effects on biomechanical properties of human bone-patellar tendon-bone allografts. Am J Sports Med (1996) 1.38
Activity- and Ca(2+)-dependent modulation of surface expression of brain-derived neurotrophic factor receptors in hippocampal neurons. J Cell Biol (2000) 1.37
Drosophila par-1 is required for oocyte differentiation and microtubule organization. Curr Biol (2001) 1.37
Morphogenesis, adhesive properties, and antifungal resistance depend on the Pmt6 protein mannosyltransferase in the fungal pathogen candida albicans. J Bacteriol (2000) 1.37
A role for Gbx2 in repression of Otx2 and positioning the mid/hindbrain organizer. Nature (1999) 1.37
Isolation of distinct small ribonucleoprotein particles containing the spliced leader and U2 RNAs of Trypanosoma brucei. J Biol Chem (1990) 1.37
Training senior house officers. BMJ (1997) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance. Clin Cancer Res (1999) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
The reliability and validity of doctor-recorded morbidity data in active data collection systems. Scand J Prim Health Care (1998) 1.31
Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes (2000) 1.31
In vivo wear of three types of metal on metal hip prostheses during two decades of use. Clin Orthop Relat Res (1996) 1.29
Beta-cell function improved by supplementing basal insulin secretion in mild diabetes. Br Med J (1976) 1.28
The hypothermia of hypoglycemia. Studies with 2-deoxy-D-glucose in normal human subjects and mice. N Engl J Med (1972) 1.28
Population bottlenecks and patterns of human polymorphism. Mol Biol Evol (1999) 1.28
A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia (2009) 1.27
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res (1992) 1.26
Inhaled benzo(a)pyrene impairs long-term potentiation in the F1 generation rat dentate gyrus. Cell Mol Biol (Noisy-le-grand) (2004) 1.26
Neurotrophin 3 potentiates neuronal activity and inhibits gamma-aminobutyratergic synaptic transmission in cortical neurons. Proc Natl Acad Sci U S A (1994) 1.24
Widespread atypical cutaneous Leishmaniasis caused by Leishmania (L.) Chagasi in Nicaragua. Am J Trop Med Hyg (1999) 1.23
Protein synthesis-dependent and -independent regulation of hippocampal synapses by brain-derived neurotrophic factor. J Biol Chem (2001) 1.23
Subacute infantile mountain sickness. J Pathol (1988) 1.22
Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J Immunol (1999) 1.21
Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol Psychiatry (2010) 1.20
GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons. Nat Neurosci (2001) 1.20
Facial corticosteroid addictive dermatitis in Guiyang City, China. Clin Exp Dermatol (2009) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. Am J Respir Crit Care Med (1996) 1.19
Localization of five annexins in J774 macrophages and on isolated phagosomes. J Cell Sci (1997) 1.19